Life sciences · Preprint
arXiv · October 14, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Designing RNA sequences that satisfy target tertiary-structure objectives is an important problem in RNA engineering, with broad applications in synthetic biology and therapeutics. Existing 3D RNA design methods have made substantial progress, but they largely treat the target fold as a geometry-only objective. This is incomplete for RNA, whose functional folds are specified not only by tertiary geometry but also by secondary base-pairing topology. We therefore formulate RNA inverse design as a topology-and-geometry co-design problem and propose TANGO, a multi-objective multi-agent reinforcement learning framework for this task. TANGO adopts a staged curriculum: it first learns a topology-aware policy from secondary-structure targets, then transfers this policy to tertiary-structure targets to train a general co-design model, and finally applies frontier-guided fine-tuning to refine target-specific trade-offs among secondary-structure fidelity, tertiary-structure fidelity, and sequence diversity. Experiments show that TANGO generates diverse and novel designs, improving tertiary- and secondary-structure performance by 18.3% and 52.7%, respectively, over the strongest baseline.